Industry

Luminopia shows promise in intermittent exotropia

Healio Optometry1d ago1 min read

Luminopia significantly improved control of intermittent exotropia in a pilot study of younger children, according to a press release.“While this is a small pilot study, the combination of improved motor control and a signal in sensory fusion suggests that dichoptic therapy warrants further investigation in larger controlled trials,” Shelley Hancock, senior director of medical affairs at Luminopia, told Healio.The study included 10 children between the ages of 4 and 7 years old who were treated with Luminopia for 3 months and checked again after a 3-month washout period. They were

Read full article on Healio Optometry

AI Summary

Quick Take

A pilot study of 10 children aged 4 to 7 found that Luminopia’s dichoptic therapy significantly improved motor control and sensory fusion in patients with intermittent exotropia. The results, observed after three months of treatment, suggest that digital binocular therapy may be a viable non-invasive approach for managing this common form of strabismus.

Why It Matters

Intermittent exotropia is a challenging condition to treat, often involving a choice between observation, patching, or surgery, with varying degrees of long-term success. Luminopia is already FDA-cleared for amblyopia, and expanding its utility to intermittent exotropia could provide clinicians with a high-compliance, home-based digital tool to improve binocularity. These findings contribute to the growing shift toward binocular, rather than monocular, treatments for pediatric vision disorders.

Key Findings

Participants showed significant improvements in the motor control of their intermittent exotropia following treatment.
The study identified a positive signal in sensory fusion, suggesting the therapy helps the brain better integrate images from both eyes.
Improvements were assessed after a 3-month active treatment phase and remained a point of interest through a subsequent 3-month washout period.
The study focused on a specific pediatric demographic of children between the ages of 4 and 7 years old.

Study Snapshot

Design

Pilot study

Population

Children with intermittent exotropia

Sample Size

10 children

Practice Implications

Clinicians managing pediatric strabismus should note the potential for dichoptic digital therapy to improve motor control in young patients. While these results are early, they suggest that engaging binocular treatments may eventually offer a way to stabilize intermittent exotropia and improve sensory outcomes before or alongside traditional surgical interventions.

Who's Affected

Pediatric OphthalmologistsPediatric OptometristsBinocular Vision Specialists

What's Next

Following this successful pilot, the therapy warrants further investigation in larger, controlled clinical trials to confirm these motor and sensory improvements across a broader patient population.

Evidence StrengthPreliminary

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.